Physician profile
Patrick C Mcaree
NPI 1841722865
$878.94
in general payments reported to CMS, 2019-2025
11 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $287 · 2024: $274 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.94 |
| Education | $162.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $234.87 | 2023-2025 | Repatha, Repatha |
| Medtronic, INC. | $162.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $160.48 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.32 | 2023-2025 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $48.37 | 2025 | Opsumit, Uptravi |
| Pfizer INC. | $45.96 | 2025 | |
| Abbott Laboratories | $23.82 | 2023 | Cardiomems |
| Merck Sharp & Dohme LLC | $19.43 | 2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $19.30 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $18.93 | 2023 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.46 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcaree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.